SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $613,000 | +4.1% | 25,840 | +20.5% | 0.03% | +3.4% |
| Q3 2019 | $589,000 | +37.9% | 21,440 | +129.6% | 0.03% | +70.6% |
| Q1 2018 | $427,000 | -85.0% | 9,340 | -86.9% | 0.02% | -86.5% |
| Q4 2017 | $2,850,000 | +383.1% | 71,540 | +84.9% | 0.13% | +384.6% |
| Q1 2016 | $590,000 | -70.7% | 38,693 | -67.4% | 0.03% | -61.2% |
| Q2 2015 | $2,017,000 | +429.4% | 118,799 | +158.2% | 0.07% | +378.6% |
| Q4 2014 | $381,000 | -74.3% | 46,013 | -73.0% | 0.01% | -79.4% |
| Q3 2014 | $1,480,000 | +337.9% | 170,355 | +451.3% | 0.07% | +277.8% |
| Q2 2014 | $338,000 | – | 30,901 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |